
Medtech company Becton Dickinson's BDX.N shares rise 1.80% to $252.06 premarket
Activist investor Starboard Value has taken a stake in BDX and is pushing the company to sell its life sciences unit, the Financial Times reported, citing people familiar with the matter
The size of Starboard's stake is unclear, the report said
The hedge fund has met company's management team and sent a letter to the board imploring the company to sell the unit, which makes products used in clinical and research laboratories, according to the report
BDX and Starboard did not immediately respond to a Reuters request for comment
Stock had fallen ~7 in 2024